Revvity, Inc. (PKN.F)
| Previous close | 96.44 |
| Open | 98.04 |
| Bid | 95.82 x 30000 |
| Ask | 97.74 x 30000 |
| Day's range | 98.04 - 98.04 |
| 52-week range | 76.50 - 118.65 |
| Volume | |
| Avg. volume | 4 |
| Market cap | 12.097B |
| Beta (5Y monthly) | 1.08 |
| PE ratio (TTM) | 71.56 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 0.26 (0.27%) |
| Ex-dividend date | 19 July 2024 |
| 1y target est | N/A |
- GlobeNewswire
Bionano Announces Software Marketing Agreement with Revvity for Newborn Sequencing Research
Bionano has entered into a software marketing agreement with Revvity, Inc. (Revvity) under which Revvity will market and commercialize Bionano’s VIA™ software to Revvity’s next generation sequencing (NGS) customers as part of its newborn sequencing research workflowVIA is expected to enhance Revvity’s newborn sequencing solution by adding an assessment of copy number variation (CNV) to the NGS solution report and streamlining the workflow’s interpretation capabilities SAN DIEGO, June 20, 2024 (G
- Business Wire
Revvity to Present at Goldman Sachs Global Healthcare Conference
WALTHAM, Mass., May 28, 2024--Revvity, Inc. (NYSE: RVTY) will present at the 45th Annual Goldman Sachs Global Healthcare Conference on Monday, June 10, 2024 at 8:00 a.m. ET in Miami, FL.
- Business Wire
Revvity Announces Financial Results for the First Quarter of 2024
WALTHAM, Mass., April 29, 2024--Revvity, Inc. (NYSE: RVTY), today reported financial results for the first quarter ended March 31, 2024.
